Cargando…
Sea lice exposure to non-lethal levels of emamectin benzoate after treatments: a potential risk factor for drug resistance
The avermectin derivative emamectin benzoate (EMB) has been widely used by salmon industries around the world to control sea lice infestations. Resistance to this anti-parasitic drug is also commonly reported in these industries. The objective of this study was to quantify the number of sea lice pot...
Autores principales: | Lam, Chun Ting, Rosanowski, Sarah M., Walker, Martin, St-Hilaire, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976678/ https://www.ncbi.nlm.nih.gov/pubmed/31969584 http://dx.doi.org/10.1038/s41598-020-57594-7 |
Ejemplares similares
-
Emamectin Benzoate Treatment of Hybrid Grouper Infected With Sea Lice in Hong Kong
por: St-Hilaire, Sophie, et al.
Publicado: (2021) -
Transcriptomic responses to emamectin benzoate in Pacific and Atlantic Canada salmon lice Lepeophtheirus salmonis with differing levels of drug resistance
por: Sutherland, Ben J G, et al.
Publicado: (2015) -
Pharmacokinetics and transcriptional effects of the anti-salmon lice drug emamectin benzoate in Atlantic salmon (Salmo salar L.)
por: Olsvik, Pål A, et al.
Publicado: (2008) -
Effects of the vertically transmitted microsporidian Facilispora margolisi and the parasiticide emamectin benzoate on salmon lice (Lepeophtheirus salmonis)
por: Poley, Jordan D., et al.
Publicado: (2017) -
Release and Degradation of Microencapsulated Spinosad and Emamectin Benzoate
por: Huang, Bin Bin, et al.
Publicado: (2017)